Antibiotics in poultry : Tyson foods' pivotal policy shift / George Joseph.

Format:

Book

Author/Creator:

Joseph, George, active 2024, author.

Series:

SAGE business cases.

SAGE business cases

Language:

English

Subjects (All):

Tyson (Firm)--Management--Case studies.

Tyson (Firm).

Social responsibility of business--Case studies.

Social responsibility of business.

Antibiotics in animal nutrition--Case studies.

Antibiotics in animal nutrition.

Physical Description:

1 online resource.

Place of Publication:

London : SAGE Publications: SAGE Business Cases Originals, 2024.

Summary:

This case study presents an in-depth analysis of Tyson Foods' policy shift regarding the use of antibiotics in poultry production. Tyson Foods, holding the position of the United States' largest poultry producer, previously adhered to a strict "no antibiotics ever" policy for eight years. However, the company recently revised this stance, permitting the utilization of antibiotics that do not impede human health. The reasons behind this substantial shift and its broad implications form the crux of our exploration. To navigate this terrain, the company has engaged a diverse set of stakeholders in a collaborative effort to uncover alternatives to antibiotics, which include options like probiotics and essential oils derived from plants. Alongside this, Tyson has shown a commitment to investing in research geared towards disease prevention. Though significant strides have been made in reducing antibiotic use, Tyson candidly acknowledges the hurdles encountered while adhering to its antibiotic withdrawal timeline. These challenges arise while ensuring a steadfast commitment to animal welfare. A visible outcome of the policy shift has been the removal of the "no antibiotics ever" label from Tyson's packaging. This has been replaced by a "no antibiotics important to human medicine" label. The crux of the matter lies in the strategic decisions Tyson Foods must make to strike a balance between animal health and human health, particularly in the context of reintroducing certain antibiotics. What steps must Tyson Foods take in order to ensure a balance between animal health and human health in the wake of reintroducing certain antibiotics? Here, disease control, growth promotion, and public health concerns overlap, offering valuable insights into Tyson's strategic decision and its potential ripple effects on the industry and public health.Keywords: Stakeholder Engagement, Sustainable Poultry Production, Alternative Treatments, Animal Welfare.

Notes:

Description based on XML content.

ISBN:

1-0719-4644-7

9781071946442

OCLC:

1417357394